205 related articles for article (PubMed ID: 19895821)
1. Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide grafting.
Brown CJ; Dastidar SG; See HY; Coomber DW; Ortiz-Lombardía M; Verma C; Lane DP
J Mol Biol; 2010 Jan; 395(4):871-83. PubMed ID: 19895821
[TBL] [Abstract][Full Text] [Related]
2. A novel unstructured scaffold based on 4EBP1 enables the functional display of a wide range of bioactive peptides.
See HY; Lane DP
J Mol Biol; 2010 Dec; 404(5):819-31. PubMed ID: 20932973
[TBL] [Abstract][Full Text] [Related]
3. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the ferric uptake regulator by peptides derived from anti-FUR peptide aptamers: coupled theoretical and experimental approaches.
Cissé C; Mathieu SV; Abeih MB; Flanagan L; Vitale S; Catty P; Boturyn D; Michaud-Soret I; Crouzy S
ACS Chem Biol; 2014 Dec; 9(12):2779-86. PubMed ID: 25238402
[TBL] [Abstract][Full Text] [Related]
5. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
[TBL] [Abstract][Full Text] [Related]
6. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition.
Borghouts C; Kunz C; Delis N; Groner B
Mol Cancer Res; 2008 Feb; 6(2):267-81. PubMed ID: 18314488
[TBL] [Abstract][Full Text] [Related]
7. Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation.
Gilch S; Kehler C; Schätzl HM
J Mol Biol; 2007 Aug; 371(2):362-73. PubMed ID: 17574575
[TBL] [Abstract][Full Text] [Related]
8. Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein.
Amano R; Takada K; Tanaka Y; Nakamura Y; Kawai G; Kozu T; Sakamoto T
Biochemistry; 2016 Nov; 55(45):6221-6229. PubMed ID: 27766833
[TBL] [Abstract][Full Text] [Related]
9. Isolation of Peptide aptamers to target protein function.
Lopez-Ochoa L; Nash TE; Ramirez-Prado J; Hanley-Bowdoin L
Methods Mol Biol; 2009; 535():333-60. PubMed ID: 19377987
[TBL] [Abstract][Full Text] [Related]
10. Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms.
Rosettani P; Knapp S; Vismara MG; Rusconi L; Cameron AD
J Mol Biol; 2007 May; 368(3):691-705. PubMed ID: 17368478
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamics of molecular recognition of mRNA 5' cap by yeast eukaryotic initiation factor 4E.
Kiraga-Motoszko K; Niedzwiecka A; Modrak-Wojcik A; Stepinski J; Darzynkiewicz E; Stolarski R
J Phys Chem B; 2011 Jul; 115(27):8746-54. PubMed ID: 21650456
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2.
Grässlin A; Amoreira C; Baldridge KK; Robinson JA
Chembiochem; 2009 May; 10(8):1360-8. PubMed ID: 19408261
[TBL] [Abstract][Full Text] [Related]
13. Ensemble and single-molecule biophysical characterization of D17.4 DNA aptamer-IgE interactions.
Poongavanam MV; Kisley L; Kourentzi K; Landes CF; Willson RC
Biochim Biophys Acta; 2016 Jan; 1864(1):154-64. PubMed ID: 26307469
[TBL] [Abstract][Full Text] [Related]
14. Ligand-regulated peptide aptamers.
Miller RA
Methods Mol Biol; 2009; 535():315-31. PubMed ID: 19377988
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamics of mRNA 5' cap binding by eukaryotic translation initiation factor eIF4E.
Niedzwiecka A; Darzynkiewicz E; Stolarski R
Biochemistry; 2004 Oct; 43(42):13305-17. PubMed ID: 15491137
[TBL] [Abstract][Full Text] [Related]
16. Structural features of human initiation factor 4E, studied by X-ray crystal analyses and molecular dynamics simulations.
Tomoo K; Shen X; Okabe K; Nozoe Y; Fukuhara S; Morino S; Sasaki M; Taniguchi T; Miyagawa H; Kitamura K; Miura K; Ishida T
J Mol Biol; 2003 Apr; 328(2):365-83. PubMed ID: 12691746
[TBL] [Abstract][Full Text] [Related]
17. Interaction between yeast eukaryotic initiation factor eIF4E and mRNA 5' cap analogues differs from that for murine eIF4E.
Kiraga-Motoszko K; Stepinski J; Niedzwiecka A; Jemielity J; Wszelaka-Rylik M; Stolarski R; Zielenkiewicz W; Darzynkiewicz E
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1711-4. PubMed ID: 14565502
[TBL] [Abstract][Full Text] [Related]
18. A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides.
Friedland DE; Wooten WN; LaVoy JE; Hagedorn CH; Goss DJ
Biochemistry; 2005 Mar; 44(11):4546-50. PubMed ID: 15766285
[TBL] [Abstract][Full Text] [Related]
19. Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor.
Potty AS; Kourentzi K; Fang H; Jackson GW; Zhang X; Legge GB; Willson RC
Biopolymers; 2009 Feb; 91(2):145-56. PubMed ID: 19025993
[TBL] [Abstract][Full Text] [Related]
20. Binding mechanism of an SH3 domain studied by NMR and ITC.
Demers JP; Mittermaier A
J Am Chem Soc; 2009 Apr; 131(12):4355-67. PubMed ID: 19267471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
